Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2023 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
MRKR on Nasdaq
Shares outstanding
16,869,505
Price per share
$1.63
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
4,044,475
Total reported value
$6,027,366
% of total 13F portfolios
0%
Share change
+552,287
Value change
+$898,868
Number of holders
36
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
New Enterprise Associates 16, L.P. 9.9% -21% $1,703,483 +$45,291 1,670,081 +2.7% New Enterprise Associates 16, L.P. 13 Nov 2025
Alyeska Investment Group, L.P. 9.9% -0.9% $1,143,378 +$188,600 1,280,952 +20% Alyeska Investment Group, L.P. 30 Sep 2025
Blue Owl Capital Holdings LP 10% +96% $1,431,356 +$727,459 1,127,052 +103% Blue Owl Capital Holdings LP 31 Mar 2025

As of 31 Dec 2025, 36 institutional investors reported holding 4,044,475 shares of Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR). This represents 24% of the company’s total 16,869,505 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) together control 24% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
NEA Management Company, LLC 9.6% 1,625,678 0% 0.12% $2,422,260
Blue Owl Capital Holdings LP 3.3% 554,250 0% 0.26% $825,833
VANGUARD GROUP INC 2.1% 346,074 +15% 0% $515,651
Aisling Capital Management LP 1.9% 325,370 0% 0.1% $484,801
UBS Group AG 1% 174,026 +2904% 0% $259,299
NewEdge Advisors, LLC 0.88% 149,000 0% $222,010
GEODE CAPITAL MANAGEMENT, LLC 0.77% 130,344 +35% 0% $194,238
RENAISSANCE TECHNOLOGIES LLC 0.73% 123,650 +16% 0% $184,239
TWO SIGMA INVESTMENTS, LP 0.58% 98,141 +169% 0% $146,230
OSAIC HOLDINGS, INC. 0.56% 94,421 +16% 0% $140,684
LPL Financial LLC 0.49% 83,247 +42% 0% $124,038
CITADEL ADVISORS LLC 0.35% 58,847 0% $87,682
XTX Topco Ltd 0.34% 58,041 +167% 0% $86,481
JANE STREET GROUP, LLC 0.24% 40,518 0% $60,372
Boyer Financial Services, Inc. 0.22% 36,817 0% 0.06% $56,698
Invst, LLC 0.16% 27,000 -6.9% 0% $40,230
NORTHERN TRUST CORP 0.15% 26,009 +140% 0% $38,753
STATE STREET CORP 0.12% 20,948 0% 0% $31,213
Creative Planning 0.1% 17,312 0% 0% $25,795
MATRIX ASSET ADVISORS INC/NY 0.09% 15,000 0% 0% $22,350
HRT FINANCIAL LP 0.08% 13,937 0% $20,000
FIFTH THIRD BANCORP 0.06% 10,000 0% $14,900
Ashton Thomas Private Wealth, LLC 0.06% 10,000 0% 0% $14,900
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 0.01% 2,000 0% $2,980
BANK OF AMERICA CORP /DE/ 0.01% 1,126 +0.27% 0% $1,678

Institutional Holders of Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 4,044,475 $6,027,366 +$898,868 $1.49 36
2025 Q3 3,455,371 $3,085,979 -$181,920 $0.89 32
2025 Q2 3,410,487 $5,218,067 -$775,167 $1.53 31
2025 Q1 4,023,536 $4,948,972 +$278,481 $1.23 31
2024 Q4 3,484,395 $10,763,745 +$4,748,926 $3.11 31
2024 Q3 1,936,917 $5,462,150 -$201,922 $2.82 27
2024 Q2 1,938,345 $10,524,473 +$162,842 $5.43 26
2024 Q1 1,911,504 $8,219,717 +$19,050 $4.30 26
2023 Q4 1,906,940 $10,488,483 +$197,065 $5.50 24
2023 Q3 1,871,217 $8,502,131 +$261,000 $4.54 26
2023 Q2 1,824,779 $5,655,903 +$1,085,797 $3.10 27
2023 Q1 1,624,962 $1,154,593 +$1,154,593 $0.71 26